Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEPRIDIL: 82 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
82
Total FAERS Reports
10 (12.2%)
Deaths Reported
52
Hospitalizations
82
As Primary/Secondary Suspect
10
Life-Threatening
1
Disabilities
Dec 28, 1990
FDA Approved
Discontinued
Status

FDA Application: 019001 ·

First Report: 201107 · Latest Report: 20241210

What Are the Most Common BEPRIDIL Side Effects?

#1 Most Reported
Interstitial lung disease
20 reports (24.4%)
#2 Most Reported
Electrocardiogram qt prolonged
8 reports (9.8%)
#3 Most Reported
Atrial fibrillation
7 reports (8.5%)

All BEPRIDIL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Interstitial lung disease 20 24.4% 4 15
Electrocardiogram qt prolonged 8 9.8% 1 6
Atrial fibrillation 7 8.5% 0 6
Bradycardia 6 7.3% 1 1
Torsade de pointes 6 7.3% 0 3
Diarrhoea 5 6.1% 0 4
Drug-induced liver injury 5 6.1% 0 0
Renal impairment 5 6.1% 0 5

Who Reports BEPRIDIL Side Effects? Age & Gender Data

Gender: 28.2% female, 71.8% male. Average age: 70.3 years. Most reports from: JP. View detailed demographics →

Is BEPRIDIL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2011 1 0 1
2012 2 0 2
2013 1 0 1
2014 6 1 4
2015 4 0 2
2016 5 3 2
2017 9 1 8
2018 6 1 4
2019 1 0 1
2020 2 0 0
2021 3 1 2
2022 2 1 2
2023 3 0 2
2024 3 0 3

View full timeline →

What Is BEPRIDIL Used For?

IndicationReports
Atrial fibrillation 31
Product used for unknown indication 27
Arrhythmia 8
Ventricular tachycardia 5

Official FDA Label for BEPRIDIL

Official prescribing information from the FDA-approved drug label.